Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …

Background: von Willebrand disease (VWD) is a common inherited bleeding disorder.
Significant variability exists in management options offered to patients. Objective: These …

Background: The management of acute and chronic pain for individuals living with sickle cell
disease (SCD) is a clinical challenge. This reflects the paucity of clinical SCD pain research …

Background: Venous thromboembolism (VTE) is the third most common vascular disease.
Medical inpatients, long-term care residents, persons with minor injuries, and long-distance …

Background: Despite an increase in the number of therapies available to treat patients with
immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist …

In February 2022, these guidelines were reviewed by an expert work group convened by
ASH. Review included limited searches for new evidence and discussion of the search …

Background: Venous thromboembolism (VTE) complicates∼ 1.2 of every 1000 deliveries.
Despite these low absolute risks, pregnancy-associated VTE is a leading cause of maternal …

Importance Manufacturers, companies, and health care professionals and organizations use
an array of promotional activities to sell and increase market share of their products and …

Background: Venous thromboembolism (VTE) is a common source of perioperative
morbidity and mortality. Objective: These evidence-based guidelines from the American …